This topic contains a solution. Click here to go to the answer

Author Question: What element has a K line with wavelength 1.46 10-11 m? A) Protactinium B) Niobium C) Uranium D) ... (Read 48 times)

burton19126

  • Hero Member
  • *****
  • Posts: 532
What element has a K line with wavelength 1.46  10-11 m?
 
  A) Protactinium B) Niobium C) Uranium D) Zirconium

Question 2

A force on an object is given by F(x) = (2.00 N/m)x + (-3.00 N/m3)x3. What is a potential energy function for this conservative force?
 
  A)
 
  2.00 N/m - 9.00x2
  B)
 
  (-2.00 N/m)x2 + (3.00 N/m3)x4
  C)
 
  -2.00 N/m + (-3.00 N/m3)x2
  D)
 
  (-1.00 N/m)x2 + (0.750 N/m3)x4
  E)
 
  -2.00 N/m + 9.00x2



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jazzlynnnnn

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

C

Answer to Question 2

D




burton19126

  • Member
  • Posts: 532
Reply 2 on: Jul 29, 2018
YES! Correct, THANKS for helping me on my review


isabelt_18

  • Member
  • Posts: 342
Reply 3 on: Yesterday
Gracias!

 

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library